New Parkinson's Disease Therapies Market Outlook & Research Updates | Most Leading Companies - AbbVie Inc., Acadia Pharmaceuticals Inc., ZAMBON COMPANY S.P.A., Eisai Co., Ltd., Acorda Therapeutics Inc

The Global Parkinson's Disease Therapeutics market reached US$ 5.51 billion in 2023 and is expected to reach US$ 10.23 billion by 2031, growing at a CAGR of 8.0% during the forecast period 2024-2031.

Parkinson's Disease Therapeutics Market report, published by DataM Intelligence, delivers detailed insights and analysis on major market trends, growth prospects, and emerging challenges. With a strong focus on providing actionable intelligence, DataM Intelligence enables businesses to make well-informed decisions and maintain a competitive edge. By blending both qualitative and quantitative research approaches, the company offers thorough reports that support clients in navigating complex market environments, driving strategic expansion, and capitalizing on new opportunities in today's rapidly evolving global landscape.

Request a Free Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://www.datamintelligence.com/download-sample/parkinsons-disease-therapeutics-market?kb

Market opportunities and Growth Drivers

✦ Innovation in Therapeutics: Introduction of groundbreaking treatments for Parkinson's disease.

✦ Alternative Treatment Options: Availability of competing therapies in the market.

✦ Dominant Drug Class: The drug class segment is set to lead the global Parkinson's disease therapeutics market.

✦ North America's Stronghold: North America is expected to maintain a major share in the global Parkinson's disease therapeutics market.

Parkinson's Disease Therapeutics Market Recent Development:

In September 2024, AbbVie revealed promising topline results from its pivotal Phase 3 TEMPO-1 trial, evaluating tavapadon as a monotherapy for early Parkinson's disease. Tavapadon, an investigational D1/D5 dopamine receptor partial agonist, is being studied as a once-daily treatment for the condition.

List of the Key Players in the Parkinson's Disease Therapeutics Market:

AbbVie Inc., Acadia Pharmaceuticals Inc., ZAMBON COMPANY S.P.A., Eisai Co., Ltd., Acorda Therapeutics, Inc., Teva Pharmaceutical Industries Ltd., Kyowa Kirin Co., Ltd., Novartis AG, Boehringer Ingelheim International GmbH and Bausch Health Companies Inc. among others.

Research Process:

Both primary and secondary data sources have been used in the global Parkinson's Disease Therapeutics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/parkinsons-disease-therapeutics-market?kb

Segment Covered in the Parkinson's Disease Therapeutics Market:

By Disease Type: Familial Parkinson's Disease, Idiopathic Parkinson's Disease, Induced Parkinsonism

By Treatment: Medications, Deep Brain Stimulation Systems, Others

By Route of Administration: Oral, Transdermal, Intravenous, Others

By Sales Channel: Distribution Channel, End-User

Regional Analysis for Parkinson's Disease Therapeutics Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

People Also Ask:

Most Frequently Asked Questions in the Parkinson's Disease Therapeutics Market Research Industry:

➠ What are the global figures for sales, production, consumption, imports, and exports in the Parkinson's Disease Therapeutics market?

➠ Who are the top manufacturers in the global Parkinson's Disease Therapeutics industry, and what is their current status in terms of production capacity, output, sales performance, pricing structure, cost analysis, profit margins, and overall revenue?

➠ What key opportunities are available for vendors in the Parkinson's Disease Therapeutics market, and what challenges are they likely to encounter?

➠ Which application areas, end-user segments, or product types are projected to experience significant growth, and how is the market share distributed among them?

➠ What are the major drivers and barriers influencing the growth trajectory of the Parkinson's Disease Therapeutics market?

➠ What are the primary sales, marketing, and distribution strategies used across the global Parkinson's Disease Therapeutics industry landscape?

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.